BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 15734027)

  • 1. Current and future role of photodynamic therapy in chronic central serous chorioretinopathy.
    Azad RV; Rani A; Pal N; Chandra P; Sharma YR
    Am J Ophthalmol; 2005 Feb; 139(2):393-4; author reply 394. PubMed ID: 15734027
    [No Abstract]   [Full Text] [Related]  

  • 2. Indocyanine green angiography-guided photodynamic therapy for treatment of chronic central serous chorioretinopathy: a pilot study.
    Shanmugam PM; Agarwal M
    Retina; 2004 Dec; 24(6):988-9; author reply 989. PubMed ID: 15580009
    [No Abstract]   [Full Text] [Related]  

  • 3. Photodynamic therapy in chronic central serous chorioretinopathy.
    Battaglia Parodi M; Da Pozzo S; Ravalico G
    Retina; 2003 Apr; 23(2):235-7. PubMed ID: 12707605
    [No Abstract]   [Full Text] [Related]  

  • 4. Correspondence.
    Narula R; Tibra NK; Narayanan R
    Retina; 2009 Jun; 29(6):867; author reply 867-8. PubMed ID: 19516125
    [No Abstract]   [Full Text] [Related]  

  • 5. Indocyanine green angiography-guided photodynamic therapy for treatment of chronic central serous chorioretinopathy: a pilot study.
    Yannuzzi LA; Slakter JS; Gross NE; Spaide RF; Costa D; Huang SJ; Klancnik JM; Aizman A
    Retina; 2003 Jun; 23(3):288-98. PubMed ID: 12824827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Photodynamic therapy for central serous chorioretinopathy using a reduced dose of verteporfin.
    Williams MA; Mulholland C; Silvestri G
    Can J Ophthalmol; 2008 Feb; 43(1):123. PubMed ID: 18219357
    [No Abstract]   [Full Text] [Related]  

  • 7. Chronic central serous chorioretinopathy: photodynamic therapy.
    Taban M; Boyer DS; Thomas EL; Taban M
    Am J Ophthalmol; 2004 Jun; 137(6):1073-80. PubMed ID: 15183792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photodynamic therapy for chronic central serous chorioretinopathy.
    Cardillo Piccolino F; Eandi CM; Ventre L; Rigault de la Longrais RC; Grignolo FM
    Retina; 2003 Dec; 23(6):752-63. PubMed ID: 14707823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety enhanced photodynamic therapy for chronic central serous chorioretinopathy: one-year results of a prospective study.
    Chan WM; Lai TY; Lai RY; Tang EW; Liu DT; Lam DS
    Retina; 2008 Jan; 28(1):85-93. PubMed ID: 18185143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced-fluence photodynamic therapy for polypoidal choroidal vasculopathy.
    Chhablani J
    Am J Ophthalmol; 2010 Sep; 150(3):443-4; author reply 444. PubMed ID: 20728684
    [No Abstract]   [Full Text] [Related]  

  • 11. [Low dose photodynamic therapy for chronic central serous chorioretinopathy].
    Cervera E; Montero J; Torralba C; Palomares P; Hernández M
    Arch Soc Esp Oftalmol; 2008 Sep; 83(9):525-6. PubMed ID: 18803123
    [No Abstract]   [Full Text] [Related]  

  • 12. Photodynamic therapy for focal retinal pigment epithelial leaks secondary to central serous chorioretinopathy.
    Ober MD; Yannuzzi LA; Do DV; Spaide RF; Bressler NM; Jampol LM; Angelilli A; Eandi CM; Lyon AT
    Ophthalmology; 2005 Dec; 112(12):2088-94. PubMed ID: 16325707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe retinal thermal injury after indocyanine green-mediated photothrombosis for central serous chorioretinopathy.
    Costa RA
    Am J Ophthalmol; 2007 Sep; 144(3):480-1; author reply 481. PubMed ID: 17765443
    [No Abstract]   [Full Text] [Related]  

  • 14. Ocular photodynamic therapy in choroidal neovascularization complicating idiopathic central serous chorioretinopathy.
    Canakis C; Conway MD; Livir-Rallatos C; Naaman GJ; Ratnakaram R; Men G; Peyman GA
    Ophthalmic Surg Lasers Imaging; 2004; 35(2):168-71. PubMed ID: 15088832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Photodynamic therapy: current role in the treatment of chorioretinal conditions.
    Newman DK
    Eye (Lond); 2016 Feb; 30(2):202-10. PubMed ID: 26742867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photodynamic therapy for focal RPE leaks.
    Koh AH
    Ophthalmology; 2006 Nov; 113(11):2110.e1-3; author reply 2111. PubMed ID: 17074572
    [No Abstract]   [Full Text] [Related]  

  • 17. Indocyanine green angiography: guided photodynamic therapy for polypoidal choroidal vasculopathy.
    Otani A; Sasahara M; Yodoi Y; Aikawa H; Tamura H; Tsujikawa A; Yoshimura N
    Am J Ophthalmol; 2007 Jul; 144(1):7-14. PubMed ID: 17467649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Photodynamic therapy of polypoidal choroidal vasculopathy.
    Rogers AH; Greenberg PB; Martidis A; Puliafito CA
    Ophthalmic Surg Lasers Imaging; 2003; 34(1):60-3. PubMed ID: 12570008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe retinal thermal injury after indocyanine green-mediated photothrombosis for central serous chorioretinopathy.
    Penha FM; Aggio FB; Bonomo PP
    Am J Ophthalmol; 2007 May; 143(5):887-9. PubMed ID: 17452182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photodynamic therapy for chronic pigment epithelial detachment in central serous chorioretinopathy.
    Chang MA; Bressler SB
    Can J Ophthalmol; 2009 Apr; 44(2):221-2. PubMed ID: 19491970
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.